Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy.
Y Miyoshi, H Uemura, K Kitami, Y Satomi… - BJU …, 2001 - search.ebscohost.com
Y Miyoshi, H Uemura, K Kitami, Y Satomi, Y Kubota, M Hosaka
BJU international, 2001•search.ebscohost.comNeuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer
after androgen deprivation therapy Page 1 CASE REPORT Neuroendocrine differentiated small
cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy Y.
MIYOSHI, H. UEMURA, K. KITAMI, Y. SATOMI, Y. KUBOTA and M. HOSAKA Department of
Urology, Yokohama City University School of Medicine, Japan Case reports Patient 1 A
59-year-old man presented with poorly differentiated prostatic adenocarcinoma, stage D1 …
after androgen deprivation therapy Page 1 CASE REPORT Neuroendocrine differentiated small
cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy Y.
MIYOSHI, H. UEMURA, K. KITAMI, Y. SATOMI, Y. KUBOTA and M. HOSAKA Department of
Urology, Yokohama City University School of Medicine, Japan Case reports Patient 1 A
59-year-old man presented with poorly differentiated prostatic adenocarcinoma, stage D1 …
Abstract
Presents clinical cases of neuroendocrine differentiated small cell carcinoma. Findings on the histopathology of the tumors; Observation of neurone-specific enolase (NSE) and chromogranin A by immunochemistry; Assessment on the serum NSE and PSA level.
search.ebscohost.com